Survey: Pharmaceutical Scientists' Salaries Rose In 1990

Buoyed by strong demand for personnel to conduct research and development programs in the quest for new products, average annual salaries for pharmaceutical scientists rose significantly in 1990, a recently released survey found. However, according to the study, the recession dampened starting pay during the same year. Healthy gains were posted by professionals in government, industry, and academia, according to the American Association of Pharmaceutical Scientists (AAPS), which sponsored the

Written byEdward Silverman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Healthy gains were posted by professionals in government, industry, and academia, according to the American Association of Pharmaceutical Scientists (AAPS), which sponsored the survey.

The average annual salary for pharmaceutical scientists in industry was $66,300, a 4.9 percent increase over the 1989 level, while pay for these scientists rose by 7.3 percent in academia, to an average of $63,100. Government employees received $57,300 on average, a 5.3 percent gain, the results showed.

By contrast, average starting pay dropped 2.5 percent, to $43,400. And average salaries for new hires in industry remained flat, at $45,100.

The survey tallied responses from 1,705 pharmaceutical scientists who in early 1991 were asked to describe their status as of December 1990. All respondents belonged to AAPS, which has a total of 6,104 members and is based in Alexandria, Va.

By far, the majority of survey respondents were employed in industry--78 percent--and most were working in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies